Author: Lu, Yan; Jiang, Yun; Ling, Lijun; Zhang, Yunyi; Li, Hong; Chen, Daofeng
Title: Beneficial effects of Houttuynia cordata polysaccharides on “two-hit” acute lung injury and endotoxic fever in rats associated with anti-complementary activities Document date: 2017_12_8
ID: q4r36tpw_2
Snippet: Acute lung injury (ALI) is characterized with respiratory dysfunction, hypoxemia with presence of diffuse pulmonary infiltrates, widespread lung inflammation 7 , increased pulmonary vascular permeability and accumulation of activated neutrophils in the lung 8 . Acute respiratory distress syndrome (ARDS) is the most severe form of ALI 9 . Complement activation is an early step in ALI 3 through both the classical pathway and the alternative pathway.....
Document: Acute lung injury (ALI) is characterized with respiratory dysfunction, hypoxemia with presence of diffuse pulmonary infiltrates, widespread lung inflammation 7 , increased pulmonary vascular permeability and accumulation of activated neutrophils in the lung 8 . Acute respiratory distress syndrome (ARDS) is the most severe form of ALI 9 . Complement activation is an early step in ALI 3 through both the classical pathway and the alternative pathway 10 . The loss of endothelial integrity in the process of ALI/ARDS also causes injured pulmonary cells to release some tissue factors or enzymes, which would lead to the initiation of complement cascade 10, 11 . A cycle of complement activation and lung injury is consequently formed. Hence, the application of complement inhibitors should be a novel treatment strategy for infectious fever and ALI.
Search related documents:
Co phrase search for related documents- acute ARDS respiratory distress syndrome and respiratory dysfunction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ARDS respiratory distress syndrome and severe form: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ARDS respiratory distress syndrome and tissue factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute ARDS respiratory distress syndrome and treatment strategy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ARDS respiratory distress syndrome and vascular permeability: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute lung injury and respiratory dysfunction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute lung injury and severe form: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute lung injury and tissue factor: 1, 2, 3, 4, 5, 6
- acute lung injury and treatment strategy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- acute lung injury and vascular permeability: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- ALI acute lung injury and respiratory dysfunction: 1, 2
- ALI acute lung injury and severe form: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- ALI acute lung injury and tissue factor: 1
- ALI acute lung injury and treatment strategy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- ALI acute lung injury and vascular permeability: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- alternative pathway and treatment strategy: 1, 2
- ARDS respiratory distress syndrome and respiratory dysfunction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- ARDS respiratory distress syndrome and severe form: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- ARDS respiratory distress syndrome and tissue factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
Co phrase search for related documents, hyperlinks ordered by date